Thoughts and attitudes of adults about medicines used for COVID-19; A descriptive study

Year 2022, , 388 - 395, 15.03.2022

Duygu Ayhan Başer , Cansu Alıcı , Betül Sultan Demir , Enes Berk Bişkiner , Asena Merve Oflaz , İzzet Fidancı , Hilal Aksoy , Mustafa Cankurtaran

https://doi.org/10.16899/jcm.984577

Abstract

Aims: With this study; it was aimed to determine the use of various medications or nutritional supplements to support immune system and opinions, usage status and attitudes towards the drugs currently used / recommended for the treatment of COVID-19, and the factors affecting drug use during the COVID-19 pandemic according to the condition of having COVID-19.
Methods: The descriptive research was conducted in Family Medicine outpatient clinics. Data were collected with a questionnaire prepared by the researchers through the internet (sites on social media) due to the pandemic. The e-questionnaire form was shared on the internet a total of 10 times at 6-day intervals.
Results: 1484 people participated, 60.8% were female, 51.5% was a healthcare professional. While 23.3% had a known disease; 19.3% of them had COVID-19 infection, 79% of them received outpatient medication. Although not recommended, it was observed that the most used drugs were Vitamin C and antipyretic drugs, followed by vitamin D and antibiotics. 87.5% who have had COVID-19 infection stated that they used the drugs as suggested/written on to them. The reasons of those who did not use drugs: fear of its side effects, not seeing it necessary, using herbal products and observing and using it if necessary. People who had live a person under the age of 18 living in the same household (p=0.042), who had a chronical disease (p=0.014) and who were regularly drug users (p=0.003) were reported that they used drugs as suggested / written on them.
Conclusion: Infodemic causes the spread of false information about the disease and its treat-ment both among the public and in scientific circles. The results of our study also support this situation. The healthcare system should be structured in accordance with the pandemic condi-tions in order to explain the importance of the use of medicines.

Keywords

COVID-19, medicines, nutritional supplements, infodemic

Project Number

yok

References

• 1. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278-280. doi:10.1111/tmi.13383
• 2. WHO (World Health Organization). WHO Coronavirus Disease (COVID‐19) Dashboard 2021. https://covid19.who.int/ Accessed: 26.04.2021
• 3. Republic of Turkey, Ministry of Health. COVID-19 Information Page. https://covid19.saglik.gov.tr/?_Dil=2 Accessed: 26.04.2021
• 4. Rosenberg ES, Dufort EM, Udo T, et al. Association of treatment with Hydroxychloro-quine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA. 2020;323(24):2493-2502. doi:10.1001/jama.2020.8630
• 5. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787-1799. doi:10.1056/NEJMoa2001282
• 6. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of COVID-19: preliminary report. N Engl J Med. doi:10.1056/NEJMoa2007764
• 7. Hacettepe Üniversitesi Tıp Fakültesi COVID-19 Pandemi Raporu (20 Mart-20 Kasım). Hacettepe İç Hastalıkları Derneği. https://covid19.tubitak.gov.tr/sites/default/files/inline-files/covid19_pandemi_raporu.pdf Accessed: 26.04.2021
• 8. https://covid19.saglik.gov.tr/TR-66926/eriskin-hasta-tedavisi.html
• 9. Hu Z, Yang Z, Li Q, Zhang A. The COVID-19 Infodemic: Infodemiology Study Analyz-ing Stigmatizing Search Terms. J Med Internet Res 2020;22(11):e22639. doi: 10.2196/22639.
• 10. The Lancet Infectious Diseases. The COVID-19 infodemic. Lancet Infect Dis. 2020;20(8):875. doi:10.1016/S1473-3099(20)30565-X
• 11. Jovic TH, Ali SR, Ibrahim N, Jessop ZM, Tarassoli SP, Dobbs TD, Holford P, Thornton CA, Whitaker IS. Could Vitamins Help in the Fight Against COVID-19? Nutrients. 2020; 12(9):2550. https://doi.org/10.3390/nu12092550
• 12. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24;323(13):1239–42. doi:10.1001/jama.2020.2648
• 13. Mario Gennaro Mazza, Rebecca De Lorenzo, Caterina Conte, Sara Poletti, Benedetta Vai, Irene Bollettini, Elisa Maria Teresa Melloni, Roberto Furlan, Fabio Ciceri, Patrizia Rovere-Querini, Francesco Benedetti. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors, Brain, Behavior, and Immunity,2020. 89: 594-600. https://doi.org/10.1016/j.bbi.2020.07.037.
• 14. Sofia Pappa, Vasiliki Ntella, Timoleon Giannakas, Vassilis G. Giannakoulis, Eleni Pa-poutsi, Paraskevi Katsaounou. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis, Brain, Behavior, and Immunity, 2020. 88: 901-907. https://doi.org/10.1016/j.bbi.2020.05.026.
• 15. Stahlmann R, Lode H. Medication for COVID-19-an Overview of Approaches Currently Under Study. Dtsch Arztebl Int. 2020;117(13):213-219. doi:10.3238/arztebl.2020.0213
• 16. Karaağaç Y, Bellikci Koyu E. Viral Enfeksiyonlarda Vitaminler ve Mineraller: COVID-19 Odağında Bir Derleme Vitamins and Minerals in Viral Infections: A Review Focus-ing on COVID-19. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2020; 5(2): 165-173
• 17. Bakan S, Deveboynu Şn , Tayhan Kartal F. The effect of antioxidant vitamins on im-munity in the COVID-19 pandemic. Eurasian JHS 2020;3(COVID-19 Special Is-sue):140-148
• 18. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
• 19. Martini N, Piccinni C, Pedrini A, Maggioni A. CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project. Recenti Prog Med. 2020 Apr;111(4):198-201. Italian. doi: 10.1701/3347.33180. PMID: 32319439.
• 20. Phelps C, Sperry LL. Children and the COVID-19 pandemic. Psychological Trauma: Theory, Research, Practice, and Policy 2020;12(1):73–75. https://doi.org/10.1037/tra0000861
• 21. Sinha IP, Harwood R, Semple MG, Hawcutt DB, Thursfield R, Narayan O, Southern KW. COVID-19 infection in children. The Lancet Respiratory Medicine 2020; 8(5): 446-447.
• 22. Hu Z, Yang Z, Li Q, Zhang A. The COVID-19 Infodemic: Infodemiology Study Analyz-ing Stigmatizing Search Terms. J Med Internet Res 2020;22(11):e22639 doi: 10.2196/22639.